PFIZER
|
The Current P/E Ratio of PFIZER is 30.74.
| Share Price | ₹4,860.2 | May 18,2026 |
| Market Cap | ₹22,210.9 Cr | |
| Earnings-TTM | ₹722.4 Cr | TTM-Standalone Results |
| Price/Earnings | 30.74x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PFIZER
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹22,210.9 Cr] as on May 18,2026
(/) Earnings [ ₹722.4 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 30.74x ]
Thus, for PFIZER , the investors are currently willing to pay 30.74 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PFIZER !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PFIZER over the last five years.
Historical PE (Price/Earnings) ratio chart of PFIZER
PE Ratio Performance Analysis for PFIZER
- PFIZER 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 31.63x.
- PFIZER 's operated at median p/e ratio of 32.5x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PFIZER 's p/e ratio peaked in Mar2021 at 41.57x.
- PFIZER 's p/e ratio hit its five-year low in Mar2025 of 23.86x.
How does PFIZER 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| PFIZER | 722.43 | 30.74 | 22,210.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 41.55 | 457,121.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 73.17 | 181,396.0 |
| CIPLA LTD | 3,869.79 | 29.78 | 115,241.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 65.46 | 148,730.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.81 | 111,126.0 |
| MANKIND PHARMA LTD | 1,796.65 | 57.36 | 103,056.0 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 20.21 | 99,737.9 |
| LUPIN LTD | 5,355.47 | 19.23 | 103,011.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 24.59 | 86,401.6 |
| ABBOTT INDIA LTD | 1,552.02 | 38.24 | 59,344.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PFIZER 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.23x |
| Max industry PE | 73.17x |
| Median industry PE | 30.74x |
| Average industry PE | 38.83x |
You may also like the below Video Courses